Advertisement

Current Infectious Disease Reports

, Volume 8, Issue 1, pp 14–22 | Cite as

How best to deal with endocarditis

  • Andrew Mark Morris
Article

Abstract

Infective endocarditis (IE) is an infection of the endocardial surface, usually involving heart valves and/or prosthetic intracardiac devices. Although much emphasis has been placed on antimicrobial prophylaxis prior to dental work to prevent IE, the evidence supporting this approach and its effectiveness are lacking. Resulting in valvular dysfunction, continuous bacteremia with constitutional features, embolic phenomena, and immune-mediated disease, diagnosis of IE requires careful history taking, physical examination, and utilization of echocardiography, blood work, and microbiologic tests. IE is uniformly fatal without effective therapy. Treatment for most cases requires prolonged courses of bactericidal antimicrobials in doses sufficient to penetrate vegetations and kill the microorganisms. Drug-resistant organisms, prosthetic intracardiac devices, comorbid illness, and valvular dysfunction often complicate therapy, necessitating a look towards adjunctive cardiac surgery. Better data (in the form of population-based surveillance and clinical trials) is beginning to impact the management of infective endocarditis.

Keywords

Endocarditis Kawasaki Disease Infective Endocarditis Linezolid Prosthetic Heart Valve 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Moreillon P, Que Y-A: Infective endocarditis. Lancet 2004, 363:139–149. This excellent review article provides a particularly good discussion of molecular pathogenesis by leaders in the field.PubMedCrossRefGoogle Scholar
  2. 2.
    Osler W: The Gulstonian lectures on malignant endocarditis. Br Med J 1885, 1:467–470, 522–526, 577–579.CrossRefPubMedGoogle Scholar
  3. 3.
    Lewis T, Grant RT: Observations relating to subacute infective endocarditis. Heart 1923, 10:21–99.Google Scholar
  4. 4.
    Elliott SD: Bacteræmia and oral sepsis. Proceedings of the Royal Society of Medicine 1939, 32:747–751.PubMedGoogle Scholar
  5. 5.
    American Heart Association: Committee report on prevention of rheumatic fever and bacterial endocarditis through control of streptococcal infections. Circulation 1955, 11:317–20.Google Scholar
  6. 6.
    Seto TB, Thomas L, Baden LR, et al.: Specialty and training differences in the reported use of endocarditis prophylaxis at an academic medical center. Am J Med 2001, 111:657–660.PubMedCrossRefGoogle Scholar
  7. 7.
    Solomon M, Raveh D, Schlesinger Y, et al.: Assessment of knowledge of guidelines for the prevention of infective endocarditis amongst clinicians in a teaching hospital. J Hosp Infect 2000, 45:311–317.PubMedCrossRefGoogle Scholar
  8. 8.
    Seto TB, Kwiat D, Taira DA, et al.: Physicians’ recommendations to patients for use of antibiotic prophylaxis to prevent endocarditis. JAMA 2000, 284:68–71.PubMedCrossRefGoogle Scholar
  9. 9.
    Northrop PM, Crowley MC: The prophylactic use of sulfathiazole in transient bacteremia following the extraction of teeth. J Oral Surg 1943, 1:19–29.Google Scholar
  10. 10.
    Morris AM, Webb GD: Antibiotics before dental procedures for endocarditis prophylaxis: back to the future. Heart 2001, 86:3–4.PubMedCrossRefGoogle Scholar
  11. 11.
    Durack DT, Kaplan EL, Bisno AL: Apparent failures of endocarditis prophylaxis. Analysis of 52 cases submitted to a national registry. JAMA 1983, 250:2318–2322.PubMedCrossRefGoogle Scholar
  12. 12.
    Tleyjeh IM, Steckelberg JM, Murad HS, et al.: Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. JAMA 2005, 293:3022–3028. This population-based study covers an uncommonly long time period, which counters some published data from tertiary-care centers regarding trends in IE.PubMedCrossRefGoogle Scholar
  13. 13.
    Horstkotte D, Follath F, Gutschik E, et al.: Guidelines on Prevention, Diagnosis, and Treatment of Infective Endocarditis. Eur Heart J 2004, 00:1–37. This article is a wonderfully referenced set of guidelines, with a European perspective.Google Scholar
  14. 14.
    Hoen B, Alla F, Selton-Suty C, et al.: Changing profile of infective endocarditis: Results of a 1-year survey in France. JAMA 2002, 288:75–81.PubMedCrossRefGoogle Scholar
  15. 15.
    Watanakunakorn C, Burkert T: Infective endocarditis at a large community teaching hospital, 1980–1990. A review of 210 episodes. Medicine (Baltimore) 1993, 72:90–102.Google Scholar
  16. 16.
    Fowler VG Jr, Miro JM, Hoen B, et al.: Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 2005, 293:3012–3021. This is one of the early publications resulting from the International Collaboration on Endocarditis (ICE), this paper nicely demonstrates the increasing importance of S. aureus IE (at least in tertiary care centers).PubMedCrossRefGoogle Scholar
  17. 17.
    Frontera JA, Gradon JD: Right-side endocarditis in injection drug users: review of proposed mechanisms of pathogenesis. Clin Infect Dis 2000, 30:374–379.PubMedCrossRefGoogle Scholar
  18. 18.
    Farrior JB, Silverman ME: A consideration of the differences between a Janeway’s lesion and an Osler’s node in infectious endocarditis. Chest 1976, 70:239–243.PubMedGoogle Scholar
  19. 19.
    Tunkel AR, Kaye D: Endocarditis with negative blood cultures. N Engl J Med 1992, 326:1215–1217.PubMedCrossRefGoogle Scholar
  20. 20.
    Werner M, Andersson R, Olaison L, et al.: A clinical study of culture-negative endocarditis. Medicine 2003, 82:263–273.PubMedCrossRefGoogle Scholar
  21. 21.
    Houpikian P, Raoult D: Blood culture-negative endocarditis in a reference center: Etiologic diagnosis of 348 cases. Medicine 2005, 84:162–173. This is the largest and most comprehensive collection of culture-negative IE, co-authored by one of the most influential microbiologists in IE research and clinical practice.PubMedCrossRefGoogle Scholar
  22. 22.
    Raoult R, Birg ML, La Scola B, et al.: Cultivation of the bacillus of Whipple’s Disease. N Engl J Med 2000, 342:620–625.PubMedCrossRefGoogle Scholar
  23. 23.
    Broqui P, Raoult D: Endocarditis due to rare and fastidious bacteria. Clin Microbiol Rev 2001, 14:177–207.CrossRefGoogle Scholar
  24. 24.
    Heidenreich PA, Masoudi FA, Maini B, et al.: Echocardiography in patients with suspected endocarditis: a cost-effectiveness analysis. Am J Med 1999, 107:198–208.PubMedCrossRefGoogle Scholar
  25. 25.
    Kuruppu JC, Corretti M, Mackowiak P, et al.: Overuse of transthoracic echocardiography in the diagnosis of native valve endocarditis. Arch Intern Med 2002, 162:1715–1720.PubMedCrossRefGoogle Scholar
  26. 26.
    Greaves K, Mou D, Patel A, et al.: Clinical criteria and the appropriate use of transthoracic echocardiography for the exclusion of infective endocarditis. Heart 2003, 89:273–275. This article presents a useful algorithm to reduce the ordering of unnecessary echocardiographs “to rule out endocarditis.PubMedCrossRefGoogle Scholar
  27. 27.
    Heiro M, Nikoskelainen J, Engblom E, et al.: Neurologic manifestations of infective endocarditis: a 17-year experience in a teaching hospital in Finland. Arch Intern Med 2000, 160:2781–2787.PubMedCrossRefGoogle Scholar
  28. 28.
    Von Reyn CF, Levy BS, Arbeit RD, et al.: Infective endocarditis: an analysis based on strict case definitions. Ann Intern Med 1981, 94:505–518.Google Scholar
  29. 29.
    Durack DT, Lukes AS, Bright DK: New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med 1994, 96:200–209.PubMedCrossRefGoogle Scholar
  30. 30.
    Li JS, Sexton DJ, Mick N, et al.: Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000, 30:633–638.PubMedCrossRefGoogle Scholar
  31. 31.
    Baddour LM, Wilson WR, Bayer AS, et al.: Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for health care professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association, Infectious Diseases Society of America. Circulation 2005, 111:e394–434. This thorough and up-to-date set of guidelines regards the diagnosis and management of IE, with an American perspective.PubMedCrossRefGoogle Scholar
  32. 32.
    Mathew J, Addai T, Anand A, et al.: Clinical features, site of involvement, bacteriologic findings, and outcome of infective endocarditis in intravenous drug users. Arch Intern Med 1995, 155:1641–1648.PubMedCrossRefGoogle Scholar
  33. 33.
    DiNubile MJ: Short-course antibiotic therapy for rightsided endocarditis caused by Staphylococcus aureus in injection drug users. Ann Intern Med 1994, 121:873–876.PubMedGoogle Scholar
  34. 34.
    Heldman AW, Hartert TV, Ray SC, et al.: Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: Prospective randomized comparison with parenteral therapy. Am J Med 1996, 101:68–76.PubMedCrossRefGoogle Scholar
  35. 35.
    de Górgolas M, Avilés P, Verdejo C, et al.: Treatment of experimental endocarditis due to methicillin-susceptible or methicillin-resistant Staphylococcus aureus with trimethoprim-sulfamethoxazole and antibiotics that inhibit cell wall synthesis. Antimicrob Agents Chemother 1995, 39:953–957.PubMedGoogle Scholar
  36. 36.
    Olaison L, Schadewitz K, Swedish Society of Infectious Diseases Quality Assurance Study Group for Endocarditis: Enterococcal endocarditis in Sweden, 1995–1999: Can shorter therapy with aminoglycosides be used? Clin Infect Dis 2002, 34:159–166.PubMedCrossRefGoogle Scholar
  37. 37.
    Birmingham MC, Rayner CR, Meagher AK, et al.: Linezolid for the treatment of multidrug-resistant gram-positive infections: Experience from a compassionate-use program. Clin Infect Dis 2003, 36:159–168.PubMedCrossRefGoogle Scholar
  38. 38.
    Gavalda J, Miro J, Torres C, et al.: Efficacy of ampicillin (A) plus ceftriaxone (Ctr) or cefotaxime (Cx) in treatment of endocarditis due to Enterococcus faecalis. Programs and Abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). Washington, DC: American Society for Microbiology; 2001:3, abstract 1342.Google Scholar
  39. 39.
    Olaison L, Hogevik H, Alestig K: Fever, C-reactive protein, and other acute-phase reactants during treatment of infective endocarditis. Arch Intern Med 1997, 157:885–892.PubMedCrossRefGoogle Scholar
  40. 40.
    Heiro M, Helenius H, Sundell J, et al.: Utility of serum C-reactive protein in assessing the outcome of infective endocarditis. Eur Heart J 2005, 26:1873–1881.PubMedCrossRefGoogle Scholar
  41. 41.
    Doulton T, Sabjarwal N, Cairns HS, et al.: Infective endocarditis in dialysis patients: New challenges and old. Kidney Int 2003, 64:720–727.PubMedCrossRefGoogle Scholar
  42. 42.
    Spies C, Madison JR, Schatz IJ: Infective endocarditis in patients with end-stage renal disease: Clinical presentation and outcome. Arch Intern Med 2004, 164:71–75.PubMedCrossRefGoogle Scholar
  43. 43.
    Alexiou C, Langley SM, Stafford H, et al.: Surgery for active culture-positive endocarditis: determinants of early and late outcome. Ann Thorac Surg 2000, 69:1448–1454.PubMedCrossRefGoogle Scholar
  44. 44.
    Piper C, Körfer R, Horstkotte D: Valve disease: prosthetic valve endocarditis. Heart 2001, 85:590–593.PubMedCrossRefGoogle Scholar
  45. 45.
    Vilacosta I, Graupner C, San Roman JA, et al.: Risk of embolization after institution of antibiotic therapy for infective endocarditis. J Am Coll Cardiol 2002, 39:1489–1495.PubMedCrossRefGoogle Scholar
  46. 46.
    Eishi K, Kawazoe K, Kuriyama Y, et al.: Surgical management of infective endocarditis associated with cerebral complications: multi-center retrospective study in Japan. J Thorac Cardiovasc Surg 1995, 110:1745–1755.PubMedCrossRefGoogle Scholar
  47. 47.
    Horstkotte D, Piper C, Wiemer M, et al.: Dringlicher Herzklappenersatz nach akuter Hirnembolie während florider Endokarditis. Med Klinik 1998, 93:284–293.CrossRefGoogle Scholar
  48. 48.
    Choussat R, Thomas D, Isnard R, et al.: Perivalvular abscesses associated with endocarditis: clinical features and prognostic factors of overall survival in a series of 233 cases. Eur Heart J 1999, 20:232–241.PubMedCrossRefGoogle Scholar
  49. 49.
    Chan K-L: Early clinical course and long-term outcome of patients with infective endocarditis complicated by perivalvular abscess. Can Med Assoc J 2002, 167:19–24.Google Scholar
  50. 50.
    Hasbun R, Vikram HR, Barakat LA, et al.: Complicated left-sided native valve endocarditis in adults: risk classi fication for mortality. JAMA 2003, 289:1933–1940. This is the first prediction rule for prognosis in IE. Awaiting further validation, it is the start of evidence-based decision-making in IE.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2006

Authors and Affiliations

  1. 1.Division of Infectious Diseases, Department of Medicine,Michael G. deGroote School of MedicineMcMaster University,McMaster Clinic 625, Hamilton General HospitalHamiltonCanada

Personalised recommendations